Continuous combined conjugated equine estrogen—progestogen therapy: Effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis

American Journal of Obstetrics and Gynecology

Volumn 167, Issue 1, 1992, Pages 1-7

  Hillard, T C ^a   Siddle, N C ^a   Whitehead, M I ^a   Fraser, D I ^a   Pryse Davies, J ^a  

^a London   (United Kingdom)

Author keywords

Continuous combined estrogen progestogen; endometrial bleeding

Indexed keywords

EQUINE ESTROGEN; MEDROXYPROGESTERONE ACETATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DRUG THERAPY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; UTERUS BLEEDING;

EID: 0026767187     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(11)91614-7     Document Type: Article

References (22)

1. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study
2. Prevention of endometrial cancer with progestogens
3. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome
4. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy
5. Cyclic changes in serum cholesterol and lipoprotein following different doses of combined postmenopausal hormone replacement therapy
6. A review of the role of progestogens in hormonal replacement therapy: influence on bleeding patterns
7. Patterns of administering cyclic/continuous estrogens
8. A simple method for determining the optimal dose of progestin in postmenopausal women receiving oestrogens
9. Effects of oestrogens and progestogens on the biochemistry and morphology of the postmenopausal endometrium
10. The effects of estrogens and progestogens on the endometrium: a modern approach to treatment
11. The role and use of progestogens
12. Amenorrhoea and endometrial atrophy with continuous oral estrogen and progestogen therapy in postmenopausal women
13. Effects of transdermal versus oral hormone replacement therapy on bone density in the spine and proximal femur in postmenopausal women
14. Continuous treatment with natural oestrogens and progestogens: a method to avoid endometrial stimulation
15. Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints
16. Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone
17. Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints
18. Continuous estrogen/progestin therapy in menopause
19. Continuous oestrogen-progestogen treatment and serum lipoproteins in post-menopausal women
20. Efficacy of a continuous estrogen-progestin regimen in the menopausal patient
21. Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient
22. Are fixed dose oestrogen/progesto-gen combinations ideal for all HRT users?